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Background: Relational models of psychopathology pro-
pose that symptoms are dynamically connected and hypoth-
esize that genetic and environmental influences moderate 
the strength of these symptom connections. Previous find-
ings suggest that the interplay between hallucinations and 
delusions may play a crucial role in the development of 
psychotic disorder. The current study examined whether 
the connection between hallucinations and delusions is 
impacted by proxy genetic and environmental risk factors. 
Methods:  Hallucinations and delusions at baseline and at 
3-year follow-up were assessed in a sample of 1054 healthy 
siblings and 918 parents of 1109 patients with psychosis, 
and in 589 healthy controls (no familial psychosis risk). 
Environmental factors assessed were cannabis use, child-
hood trauma, and urbanicity during childhood. Logistic 
regression analyses tested whether familial psychosis risk 
predicted increased risk of delusions, given presence of hal-
lucinations. Moderating effects of environmental factors 
on the hallucination-delusion association were tested in a 
similar fashion, restricted to the control and sibling groups. 
Results:  The risk of delusions, given hallucinations, was 
associated with proxy genetic risk: 53% in parents, 47% in 
siblings, and 36% in controls. The hallucination-delusion 
association was stronger in those reporting cannabis use 
(risk difference: 32%) and childhood trauma (risk differ-
ence: 15%) although not all associations were statistically 
conclusive (respectively: p = .037; p = .054). A direction-
ally similar but nonsignificant effect was found for urb 
anicity during childhood (risk difference: 14%, p = .357). 
Conclusion: The strength of the connection between delu-
sions and hallucinations is associated with familial and 
environmental risks for psychotic disorder, suggesting 
that specific symptom connections in the early psychosis 
psychopathology network are informative of underlying 
mechanisms.
Key words:  hallucinations/delusions/psychosis
Introduction
The occurrence of psychotic experiences in the general 
population may be viewed as the behavioral expression 
of underlying psychosis liability.1 General population 
studies have consistently shown that psychotic experi-
ences occur in around 8%2 of the population, the major-
ity never converting to clinical psychosis. The relative risk 
for transition to clinical psychotic disorder, given pres-
ence of baseline subthreshold psychotic symptoms, is 
around 3.5, which translates to a yearly incidence rate of 
less than 1%.3 The dynamics underlying transition to clin-
ical outcome have been captured by the psychosis prone-
ness-persistence-impairment model, which proposes that 
normally transient subclinical expression of psychosis, 
under the influence of environmental and familial risk 
factors, becomes more persistent over time. Persistence 
of symptoms, in turn, increases risk of impairment and 
clinical outcome.1
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For the study of early psychosis, psychopathology can 
be represented as categories of mental disorder (group-
ings based on clustering of individuals), symptom dimen-
sions (scores on a factor of clustered symptoms),4 or 
symptom networks (symptoms impacting on each other 
as part of a circuit or network).5 An example of the latter 
is that delusions with a threatening content (eg, delusions 
of persecution) may provoke feelings of anxiety; anxiety 
in turn may lead to greater alertness for threatening cues 
(eg, people giving unfriendly looks) supportive of the 
notion that others are malevolent and threatening, thus 
strengthening the delusional ideation. Symptoms thus 
can impact on each other and become interconnected, 
suggesting that psychopathology can be modeled as a 
network of mutually impacting experiences.6–8 Research 
has indicated that risk for transition to clinical outcomes 
may be related to dynamic relationships between sub-
threshold symptoms,9 impacting on each other over time. 
Thus, associations between subthreshold psychotic expe-
riences on the one hand, and co-occurring symptoms of 
anxiety and depression, as well as negative symptoms on 
the other, impact on each other’s severity over time, thus 
increasing risk for functional impairment and transition 
to clinical psychotic disorder.10–12 In addition, psychotic 
experiences impact on themselves over time, showing 
more or less persistence, more persistence being associ-
ated with greater probability of clinical transition.13
A relatively novel area in empirical models of symp-
tom connections involves the interplay between hallu-
cinations and delusions in the early stages of psychosis. 
This is of particular interest, given theories on how delu-
sions may arise secondarily to hallucinatory experiences, 
as described in the work of Maher on anomalous per-
ceptual experiences14 and Kapur on aberrant salience.15 
In this work, the differentiation between primary delu-
sions (ie, delusions that arise spontaneously and are the 
result of reasoning bias) and secondary or explanatory 
delusions (ie, delusions formed as an explanation, which 
can be understood in the light of a persons’ background) 
represents a crucial distinction. The early phases of psy-
chosis may be marked by “perceptual changes” or “hal-
lucinatory experiences,” which give rise to a puzzling or 
bewildered feeling that warrants an (odd) explanation. 
The formation of secondary delusional ideation follow-
ing hallucinatory experiences increases the risk of defi-
cits in social functioning and subsequent onset of clinical 
needs.14,15 Many models have, at least in part, adopted the 
notion that delusions combine with hallucinations in the 
early stages of psychosis.16–21
The association between subthreshold hallucinatory 
and delusional experiences has recently been the object 
of empirical analysis. One general population study dis-
tinguishing between groups, reporting (1) no psychotic 
experiences, (2) only hallucinations, (3) only delusions, 
and (4) both hallucinations and delusions, found that 
having both symptoms, as opposed to having either one in 
isolation, resulted in increased symptom severity and per-
sistence, as well as increased risk of clinical outcome and 
need for care.22 This finding was replicated in 2 general 
population studies,23,24 as well as a study from the World 
Health Organization.25 Further findings from these stud-
ies indicated that combined hallucinations and delusions, 
as opposed to either symptom in isolation, are associated 
with (1) greater environmental etiological load (childhood 
trauma, cannabis use, urbanicity),22,23,25 (2) familial liabil-
ity to psychosis,22,23 and (3) affective dysregulation,22,23,25 
all known risk factors for psychotic disorder.12,26–28 These 
findings are compatible with suggestions that hallucina-
tions and delusions are dynamically associated with each 
other, giving rise to a “hallucinatory-delusional” state in 
which hallucinations and delusions are connected under 
the influence of environmental risks, affective dysregula-
tion and familial liability, increasing probability of need 
for care, and clinical outcome.
Further evidence for the importance of an early “halluci-
natory-delusional” state comes from studies focusing on the 
sequence in which symptoms arise. A virtual reality study 
investigated which factors (intellectual functioning, emo-
tional processes, reasoning styles, social factors, and anom-
alous perceptual experiences) were predictive of increased 
levels of state anxiety and paranoia in healthy controls.29 
Findings showed that the only specific predictor for state 
paranoia was proneness to anomalous perceptual experi-
ences,29 indicating that hallucination proneness is predictive 
of paranoid ideation in healthy controls. These results are 
further underscored by 2 longitudinal studies in children 
measuring hallucinations at baseline and delusional ide-
ation at 5-year follow-up. Results showed that persistent 
hallucinations at baseline and follow-up predict develop-
ment of delusions over follow-up.30,31 Similar effects were 
found for adults in a general population longitudinal study, 
indicating that baseline hallucinatory experiences, when 
complicated by delusions at follow-up, resulted in increased 
risk for clinical psychosis, as compared to baseline hallu-
cinations without subsequent delusional ideation.32 These 
findings suggest that the pathway from hallucinatory expe-
riences to clinical psychosis may be mediated, at least in 
part, by secondary formation of delusions.
Given the fact that co-occurrence of hallucinations 
and delusions in the general population is associated with 
familial risk for psychosis,22,23 the current study aimed to 
investigate the influence of familial liability on co-occur-
rence of hallucinations and delusions, in more detail 
than before, in a sample with increased genetic risk for 
psychosis. Data from the Genetic Risk and Outcome of 
Psychosis (GROUP)33 study were used, including healthy 
siblings of affected families (hereafter: healthy siblings 
OAF), their parents, and healthy controls. As healthy sib-
lings of affected patients share 50% of their genes and a 
proportion of environmental exposure with patients, have 
a degree of subclinical expression of psychosis, but are 
free of illness-related factors (alterations in functioning 
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due to clinical psychopathology or medication effects), 
sibling status represents a suitable index for investigating 
the effects of familial liability on patterns of subclini-
cal psychotic symptomatology. Studies have shown that 
siblings are at increased risk of psychosis34,35 and display 
higher rates of schizotypal traits,36–39 suggesting expres-
sion of familial liability to psychosis. In the current study, 
it was hypothesized that controls would exhibit the low-
est rate of co-occurring hallucinations and delusions, 
and healthy siblings OAF and parents, having increased 
genetic risk, would show higher rates of co-occurring hal-
lucinations and delusions.
In addition, following previous findings that the co-
occurrence of hallucinations and delusions show a stron-
ger association with environmental factors22,23,25 than 
isolated hallucinations or delusions, the second hypoth-
esis under investigation was that environmental factors 
(growing up in an urban environment, childhood trauma, 
and cannabis use) moderate the strength of the connec-
tion between hallucinations and delusions.
Methods
Data pertain to baseline (T0) and follow-up (T1) mea-
surements of  an ongoing longitudinal study (GROUP) 
in the Netherlands and Belgium including patients, 
their parents, their healthy siblings, and a group of 
healthy controls. In selected representative geographi-
cal areas, patients were identified through represen-
tative clinicians whose caseload was screened for 
inclusion criteria. Subsequently, a group of  patients 
presenting consecutively at these services either as out- 
or inpatients were recruited for the study. Controls 
were selected through a system of  random mailings 
to addresses in the catchment areas of  the cases. The 
baseline sample and the sampling procedure have been 
described in detail previously.33 Baseline inclusion cri-
teria for the patient group were (1) age between 16 
and 60  years, (2) mastery of  the Dutch language, (3) 
the ability and willingness to sign informed consent, 
and (4) a diagnosis of  nonaffective psychosis based 
on the Comprehensive Assessment of  Symptoms and 
History Interview (CASH).40 The following additional 
criteria were used for the control and healthy siblings 
OAF group: (1) no lifetime history of  any psychotic 
disorder (healthy siblings OAF and controls) and (2) 
no first-degree relative with any lifetime psychotic dis-
order (controls only). The T1 measurements were car-
ried out 2.9 years after baseline with the exception of 
parental measurements, as parents were only assessed 
at baseline. At both T0 and T1, instruments regard-
ing symptoms, diagnosis, and environmental risk were 
administered. Trained research assistants administered 
all interviews and were instructed to prompt with fol-
low-up questions in case of  a positive answer to the 
CASH items in order to identify false positives. All 
diagnoses and psychopathology ratings were assessed 
in consensus meetings chaired by a consultant psy-
chiatrist. The project was approved by the local Ethics 
Committee and all participants gave written informed 
consent prior to participating in the study.
The full GROUP sample at T0 comprised 1119 patients 
with nonaffective psychosis, 1057 healthy siblings OAF, 
918 parents, and 589 unrelated healthy controls. In the 
current analyses, only data from the control, healthy 
sibling OAF, and parent groups were used. Participants 
from one site, which did not use the CASH40 to assess 
psychotic symptoms, were excluded from the analyses.
Measurements
The Comprehensive Assessment of Symptoms and History. 
The hallucination section of the CASH40 was used to 
assess auditory, visual, olfactory, and somatic halluci-
nations at both the T0 and T1 interview. Dichotomous 
measures were created indicating the reported presence 
(1) or absence (0) of hallucinations at baseline (hereafter 
any baseline hallucination(s) as measured by the T0 life-
time version of the CASH) and at follow-up (ie, any T1 
hallucination(s)). A variable was creating that indicated 
the presence or absence of any hallucination(s) at the T0 
and T1 interview (0: “no hallucinations at baseline or at 
T1” and 1: “any hallucination(s) at baseline and or T1”), 
which was used in the current analyses.
Delusions. CASH delusion items (section 6)  included 
the following types of delusions: persecution, jealousy, 
guilt, grandiosity, religious, somatic, ideas of reference, 
being controlled by an external force, being able to read 
other persons’ thoughts, thoughts being read by others 
or thought broadcasting, and thoughts being inserted or 
withdrawn by an external source. Each item was assessed 
individually, and an overall score representing absence 
(0) or presence (1) for any baseline delusion(s) (T0) and 
any T1 delusion(s) (T1) was created. Again, a variable 
representing presence of any delusion(s) was created by 
combining scores of any baseline delusion(s) and any T1 
delusion(s) (0: “absent” and 1: “present”), which was 
used in the current analyses.
Environmental Factors 
Urbanicity Urbanicity before the age of 15  years was 
obtained via a questionnaire which inquired about each 
home address before the age of 15. For each reported 
address, a population density record was calculated with 
the aid of historical population density records. Next, the 
average population density over the period 0–14 years of 
age was calculated in accordance with the Dutch CBS 
urbanicity rating (1 = <500/km2; 2 = 500–1000/km2; 3 
= 1000–1500/km2; 4 = 1500–2500/km2; 5 = 2500+/km2), 
or Belgium equivalent, as described in more detail else-
where.41–43 A  median split in the healthy control group 
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data was used to indicate above (1) or below (0) median 
exposure to urbanicity before the age of 15 years.
Childhood Trauma The variable for Childhood trauma was 
constructed with the Childhood Trauma Questionnaire 
– Short Form (CTQ- SF; Dutch version),44,45 measuring 
exposure to physical, emotional, and sexual abuse, and 
physical and emotional neglect during childhood. Each 
item was rated on a 6-point scale (0: “never true” and 5: 
“very often true”). A mean item score was calculated for 
the CFQ-SF after which the median split based on control 
group data was used to divide the groups in high (1) and 
low childhood trauma exposure (0).
Cannabis At baseline, recent cannabis use was measured 
by urine analysis by the National Alcohol and Drug Use 
Jellinek Laboratory in the Netherlands. The cutoff  level 
used to determine cannabis use as present or absent was 
50 ng/ml. Given the conservative cutoff  level of 50 ng/ml, 
the timeframe for detecting cannabis use was approxi-
mately 1 month. A measure for recent cannabis use was 
created (negative, 0: “absent” and positive, 1: “present”).
Analyses
All analyses were conducted in STATA version 1146 with 
GROUP data release version 3.02. The variable Group 
had 3 levels and was coded as 0 (controls), 1 (healthy 
siblings OAF), and 2 (parents). Data were analyzed in 
the “long format” (STATA terminology) with each sub-
ject contributing 2 (T0 and T1) rows of observations 
to the analysis, conforming to previous work in this 
area,22,23 except for parents, who were only assessed at T0. 
Therefore, the n reported throughout the paper refers to 
number of observations rather than number of subjects (ie, 
subjects contributing multiple observations). This means 
that the analyses reported below were cross-sectional in 
nature. Since there were multiple observations per sub-
ject, and some families contributed more than one rela-
tive, all analyses were controlled for clustering of data at 
both the family and the subject level by adding family 
and subject ID to the models as random intercepts.
Demographic differences were assessed with ANOVA 
analyses (for continuous variables) and logistic regression 
(for dichotomous variables), quantifying possible differ-
ences in the sample between groups and between T0 and 
T1, which were deemed significant if  p ≤.05.
Hypothesis I: Do Hallucinations and Delusions 
Co-occur and Is This Association Stronger for Those 
With Higher Familial Psychosis Risk?
The co-occurrence of hallucinations and delusions 
was assessed by calculating the proportion with any 
delusion(s) per group (0 = controls, 1 = siblings, 2 = par-
ents), given the presence or absence of hallucinations. 
These proportions are presented for descriptive purposes 
in the results section.
The analyses carried out to investigate Hypothesis 
I involved 2 different steps. The first step was to investi-
gate whether there was an interaction effect of any hal-
lucination × group on delusional outcome. This was done 
with the aid of multilevel logistic regression, tested with 
the aid of the XTMELOGIT command in STATA, con-
trolling for age, sex, and clustering of data at the subject 
and family level by adding family and subject ID to the 
model as random intercepts.
The second part consisted of an investigation of the 
simple effects of  group on delusional outcome, given the 
presence or absence of hallucinations. Investigating the 
simple effects allows for a more detailed account of the 
association between group and presence or absence of 
any hallucination on delusional outcomes. These analy-
ses investigated 2 main factors. First, it was investigated 
whether the risk of having delusions (dependent variable) 
was greater for individuals with compared to those with-
out hallucinations (independent variable) within groups. 
This was done with the aid of 3 different post hoc com-
parisons (ie, Comparison 1: controls without halluci-
nations vs controls with hallucinations; Comparison 2: 
healthy siblings OAF without hallucinations vs healthy 
siblings OAF with hallucinations; Comparison 3: parents 
without hallucinations vs parents with hallucinations). 
The second factor was whether the risk of having delu-
sions, given the presence of hallucinations differed as a 
function of familial liability, that is whether this risk dif-
fered across groups (ie, group: controls, healthy siblings 
OAF, and parents). Again, 3 different post hoc compar-
isons were used to test whether there was difference in 
risk between groups (Comparison 1: controls with hal-
lucinations vs healthy siblings OAF with hallucinations; 
Comparison 2: controls with hallucinations vs parents 
with hallucinations; Comparison 3: healthy siblings OAF 
with hallucinations vs parents with hallucinations).
An alternate way in which the within- and between-
group effects described above was investigated is by con-
structing 3 different models, with each model comparing 
the effect of presence or absence of hallucinations on 
delusional outcome in 2 different categories of group 
(Model 1: controls vs healthy siblings OAF; Model 2: 
controls vs parents; Model 3: healthy siblings OAF vs 
parents). A  more detailed description of these models 
can be found in the supplementary section S1.
Hypothesis II: Do Environmental Factors Moderate the 
Strength of the Connection Between Hallucinations and 
Delusions?
The analysis investigating whether the strength of  the 
connection between hallucinations and delusions was 
moderated by the selected environmental factors was 
carried out in the control and healthy siblings OAF 
data only, since environmental data in the parent group 
were not assessed at T0. Multilevel logistic regression 
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models assessed the main interaction effect between 
hallucinations and environmental factors on delu-
sion occurrence in data combining the control and the 
healthy siblings OAF groups. For each type of  exposure 
(respectively urbanicity, childhood trauma, and cannabis 
use), an analysis including an interaction term of  envi-
ronmental exposure × hallucinations was carried out. 
Comparable to the analyses of  the first hypothesis, in 
the second phase of  the analysis, the simple effects of 
environmental exposure and presence of  hallucinations 
on delusional outcome were investigated. For each envi-
ronmental exposure, a separate analysis was carried out. 
The model included any hallucination(s) (at either T0 
or T1), together with the investigated environmental 
risk factor (respectively urbanicity, childhood trauma, 
and recent cannabis use) and tested the simple effect of 
any hallucination(s) and the environmental factor, with 
any delusion(s) as outcome variable. The interaction 
between any hallucination(s) and the environmental 
factors was tested in a similar fashion as described for 
the first hypothesis. For each environmental exposure, a 
dummy variable was created (hallucination by urbanic-
ity, hallucination by trauma, and hallucination by can-
nabis). Each of  these variables contained 4 levels (Level 
1: 0-0, no hallucination(s), environmental risk factor 
absent; Level 2: 1-0, any hallucination(s), environmen-
tal risk factor absent; Level 3: 0-1, no hallucination(s), 
environmental risk factor present; Level 4: 1-1, any 
hallucination(s), environmental risk factor present). 
Chi squares (χ2) were available for each level of  the any 
hallucination(s) and environmental exposure interac-
tion, with Level 1 as reference category. For each anal-
ysis, Level 2 vs 4 comparisons were made in order to 
assess the effect of  the environmental exposure and co-
occurrence of  delusions, given the presence of  halluci-
nations. All analyses were controlled for age, sex, and 
clustering of  observations at the family- and subject-
level by adding family and subject ID to the model as 
random intercepts. All analyses were conducted in the 
combined T0 and T1 data, each individual contributing 
2 rows (T0 and T1).
Results
Sample
The T0 sample consisted of 1057 healthy siblings OAF, 
918 parents, and 589 unrelated healthy controls. The T1 
sample included 810 healthy siblings OAF and 462 con-
trols. Follow-up rates for the healthy siblings OAF and 
the control groups were 76.6% and 78.4%, respectively. 
Mean time to follow-up was 2.9  years. Descriptive sta-
tistics of the sample are given in table  1. At both time 
points, controls were more likely to be older, white, 
female, and of higher educational level than healthy sib-
lings OAF. Participants who completed both T0 and T1 
measurements, on average, had a higher educational level 
and more often were of White ethnic origin than those 
who only participated at T0.
The number of individuals with valid CASH data at 
baseline was 1942, who over baseline and follow-up con-
tributed a total of 2598 observations (764 in controls, 
1165 in healthy siblings OAF, and 669 in parents).
Hypothesis I: Do Hallucinations and Delusions 
Co-occur and Is This Association Stronger for Those 
With Higher Psychosis Risk?
First, co-occurrence rates for hallucinations and delu-
sions were investigated per group (table 2). In the control 
group, 92.0% (n = 703) reported no psychotic symptoms, 
4.3% (n = 33) reported only delusions, 2.4% (n = 18) 
reported only hallucinations, and 1.3% (n = 10) reported 
both. In the healthy siblings OAF group, 86.3% (n = 
1005) reported no symptoms, 7.0% (n = 82) reported only 
delusions, 3.5% (n = 41) reported only hallucination(s), 
and 3.2% (n = 37) reported hallucinations as well as delu-
sions. For parents, this was, respectively, 88.0% (n = 589), 
6.6% (n = 44), 2.5% (n = 17), and 2.8% (n = 19).
Second, it was investigated whether reporting any 
delusion(s) differed as a function of presence or absence 
of any hallucination(s) (ie, reporting only delusions vs 
co-occurring delusions and hallucinations). The results 
showed that for controls, siblings, and parents, the prob-
ability of reporting delusions, given the presence of any 
hallucination(s), was higher as compared to absence of 
hallucinations (table 3).
No significant differences were found in the occurrence 
of any delusion(s) between the healthy controls, healthy 
siblings OAF, and parent groups, given absence of any 
hallucination(s). The main interaction effect of group × 
any hallucination on delusional outcome was investigated. 
Results showed no significant interaction of group (con-
trol [reference] vs healthy sibling OAF: p = .747, control 
[reference] vs parents: p = .757). However, the probability 
of reporting any delusion(s), given the presence of any 
hallucination(s), was stronger for groups with increased 
psychosis risk (figure  1). The regression analyses inves-
tigating the effect of hallucinations and proxy genetic 
risk categories on delusions showed that parents had an 
increased probability of delusions, given presence of hal-
lucinations, compared to controls (χ2 = 5.04, p = .03), and 
to healthy siblings OAF (χ2 = 4.18, p = .04). The differ-
ence in probability of delusions, given presence of hallu-
cinations, between healthy siblings OAF and controls was 
directionally similar to that observed in the parent group 
(figure 1), albeit not significant (χ2 = 0.52, p = .47). When 
these contrasts were investigated with the aid of 3 differ-
ent models, the results remained by and large the same, 
except for the fact that the found difference between par-
ents and healthy siblings OAF was no longer significant, 
caused by the change in random effect estimators (see 
supplementary table 1).
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Hypothesis II: Do Environmental Factors Moderate the 
Strength of the Connection Between Hallucinations and 
Delusions?
Multilevel logistic regression models tested the interac-
tion between presence of  any hallucination(s) and each 
of  the 3 environmental factors (ie, recent cannabis use, 
urbanicity, and childhood trauma). Results showed 
no significant main interaction effects for urbanicity 
× any hallucination (p = .14) and for childhood trauma 
× any hallucination (p = .28) but did find a significant 
interaction for the recent cannabis use × any hallucina-
tion term (p = .02). The model testing the simple effects 
of  environmental risk factors and hallucination on any 
delusion showed associations in the expected direction 
(ie, stronger association between hallucinations and 
delusions in the exposed vs nonexposed groups) (for 
results, see table 4). The moderating effect was signifi-
cant or borderline significant for cannabis use (p = .037) 
and childhood trauma (p = .054), but not for urbanicity 
(p = .357).
Table 2. Reported Symptoms per Group
Group Na
No Psychotic  
Symptoms, % (n)a Only Hallucinations, % (n)a Only Delusions, % (n)a
Both Hallucinations 
and Delusions, % (n)a
Controls 764 92.0 (703) 2.4 (18) 4.3 (33) 1.3 (10)
Siblings 1165 86.3 (1005) 3.5 (41) 7.0 (82) 3.2 (37)
Parents 669 88.0 (589) 2.5 (17) 6.6 (44) 2.8 (19)
Note: aRefers to repeated observations in individuals (except parent group that was only assessed once at baseline).
Table 3. The Association Between Any T0 or T1 Hallucination and Any T0 or T1 Delusion, Reported Separately for the Different 
Groupsa
Group N
Proportion 
Reporting Any 
Hallucination, 
% (n)
Proportion 
Reporting Delusions 
Given Absence of 
Hallucinations, % (n)
Proportion 
Reporting Delusions 
Given Presence of 
Hallucinations, % (n) Difference (%)
Association  
χ2, pa,b
Controls 764 3.7 (28) 4.5 (33/736) 35.7 (10/28) 31.2 χ2 = 22.71, p < .001
Siblings 1165 6.7 (78) 7.5 (82/1083) 47.4 (37/78) 39.9 χ2 = 28.66, p < .001
Parents 669 5.4 (36) 7.0 (44/625) 52.8 (19/36) 45.8 χ2 = 28.66, p < .001
Notes: aAll analyses refer to multilevel logistic regression analyses controlled for age, sex, group, and clustering of observations within 
subjects, with delusions as dependent variable and “any T0 or T1 hallucination” as independent variable.
bRepresents the within-group effect of the presence of hallucinations on the probability of delusions. The proportions in the table, and 
differences between them, are presented for descriptive purposes only.
Fig. 1. Multilevel logistic regression analyses of the probability of delusional ideation as a function of hallucinations, showing 
differences in the strength of the connection between delusions and hallucinations across 3 groups with variable psychosis risk. 
*p < .05. Hallucination (−) = “no hallucination(s)” and hallucination (+) = “any hallucination.” Grey bars represent the proportion 
of individuals reporting delusions in the absence of hallucinations; black bars: the proportion of individuals reporting delusions in the 
presence of any hallucination. Analyses controlled for age, sex, and clustering of observations at subject and family level.
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Discussion
Findings
Previous investigations have consistently reported that 
hallucinations and delusions cluster more often than 
would be expected by chance.22,23,25 The current study 
extends this finding from the general population to a sib-
ling and parent sample of affected families. There was 
no main interaction of any hallucinations × group in the 
model of delusional ideation. Interaction analyses, how-
ever, have low power, given the low rates of co-occurrence 
in particularly the controls. When examining the simple 
effects of any hallucination and group on delusional out-
come, the findings suggested that, given the presence of 
hallucinations, a dose-response relationship exists such 
that greater psychosis risk was associated with greater 
levels of co-occurrence of hallucinations and delusions. 
A  dose-response effect was not apparent for hallucina-
tions or delusions occurring in isolation, indicating that it 
is not the mere presence of a symptom, but rather the co-
occurrence of both that serves as a discriminating factor 
between healthy and affected families. Furthermore, the 
findings indicate that environmental risk factors (canna-
bis exposure and childhood trauma) are associated with 
increased co-occurrence of hallucinations and delusions. 
Although not all reported differences were statistically 
conclusive, the pattern of the results nevertheless was 
consistent with previous work.22,23 The findings indicate 
that the pattern of co-occurring hallucinations and delu-
sions between controls and healthy siblings OAF is in the 
expected direction (siblings showing increased co-occur-
rence), however this pattern was not statistically signifi-
cant. Several explanations could be given for the finding 
that healthy siblings OAF appear to resemble controls 
more than was a priori expected. First, healthy siblings 
of patients, more than parents, may answer defensively 
to questions about psychopathology.47,48 Additionally, 
the healthy siblings OAF who took part in the study may 
have represented the group of siblings with relatively 
low expression of psychotic experiences. These factors 
may have resulted in a degree of underestimation of the 
association between hallucinations and delusions in this 
group. Therefore, the addition of a large sample of par-
ents in the current study can be considered a strength.
The current findings form a replication of  previous 
findings indicating that the co-occurrence of  halluci-
nations and delusions is associated with familial and 
environmental risk.22,23 Furthermore, studies have con-
sistently shown that clustering of  hallucinations and 
delusions leads to greater symptom severity and per-
sistence of  symptoms,22–25 as predicted by the psychosis 
proneness-persistence-impairment model.1 This find-
ing, combined with evidence from previous findings 
that the psychotic state deepens when hallucinations 
become complicated by delusions22–25,32 is supportive of 
the theoretical frameworks proposed by Maher14 and 
Kapur15 in which early psychosis is marked by a phase 
in which anomalous perceptual experiences connect with 
secondary (explanatory) delusional ideation. The theo-
retical framework, in which hallucinations and delusions 
interact with each other, is in line with recent network 
theories of  psychopathology that state that symptoms 
are not a mere passive expression of  underlying liabil-
ity but interact with each other and have an active role 
in disorder onset.5,8,9 The interaction between hallucina-
tions and delusions thus can be viewed as a crucial con-
nection in the symptom network underlying psychosis. 
Taken together, the findings lend credence to the notion 
of  a “hallucinatory-delusional state” in which hallucina-
tions and delusions become connected under the influ-
ence of  environmental and familial risk factors, resulting 
in greater severity and persistence of  symptoms, and a 
deepening of  the psychotic state.
Given the fact that the findings on the connection 
between hallucinations and delusions in (sub)clini-
cal psychosis are robust and replicable,22–25 a search for 
biological substrates of this connection is warranted. 
Dopaminergic dysregulation may be the starting point of 
Table 4. The Moderating Effect of Environmental Factors on the Risk of Delusions Given Hallucinations
Exposure type na
Proportion 
exposed, % (n)
Proportion with 
delusions given  
absence of 
hallucinations, % (n)
Proportion with 
delusions given 
presence of 
hallucinations, % (n)
Difference 
(%)
Effect size 
environmental 
factor (%)
Interaction  
χ2, p
Cannabis urinalysis + 1827 6.2 (114) 10 (10) 73.3 (11) 63.3 31.6 χ
2 = 4.3, p = .037
Cannabis urinalysis − 93.8 (1713) 6.2 (100) 37.9 (33) 31.7
Childhood trauma + 2628 51.5 (1352) 8.1 (62) 44.6 (25) 36.5 15.2 χ
2 = 3.7, p = .054
Childhood trauma − 48.6 (1276) 6.8 (33) 28.1 (9) 21.3
Urbanicity <age 15 + 3072 47.5 (1612) 5.6 (47) 52.1 (25) 46.5 14.4 χ
2 = 0.9, p = .357
Urbanicity <age 15 − 52.5 (1460) 7.0 (60) 39.1 (18) 32.1
Note: aAll analyses carried out in combined data of the control and sibling group and refer to multilevel logistic regression analyses 
controlled for age, sex, group, and clustering of observations within subjects, with delusions as dependent variable and the “any T0 or T1 
hallucination × environmental factor” interaction as independent variable.
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the psychotic cascade15,49 which is supported by the find-
ing that presynaptic dopaminergic abnormalities associ-
ated with psychotic disorder are not present in healthy 
individuals reporting auditory hallucinations,50 but 
instead appear as early psychosis progresses to the clini-
cal state.51 Furthermore, findings suggest that in popula-
tions at high risk for psychosis, antipsychotic medication 
dampens experiences of aberrant salience, whereas cogni-
tive behavioral therapy changes delusional ideation and 
associated biases.18 These findings indicate that dopami-
nergic alterations may mediate the process in which mean-
ing is attached to perceptual abnormalities, giving way to 
a delusional interpretation of the perceptual changes.
Methodological Considerations for Future Studies
The following methodological issues should be taken into 
consideration for future studies. Firstly, the current study 
used analyses that were cross-sectional in nature to inves-
tigate the association between hallucinations and delu-
sions across groups. Therefore, no conclusions can be 
drawn on the temporality of the connection between hal-
lucinations and delusions. Future studies might benefit 
from more frequent and fine-grained follow-up in order 
to investigate the temporality of symptom onset. The 
current study found lower rates of co-occurrence of hal-
lucinations and delusions in the healthy controls (1.3%) 
than previous studies, which reported co-occurrence of 
hallucinations and delusions in 2.0%–2.5% in general 
population samples.22,23,25 As a recent review found strong 
evidence that assessment type accounts for a large part of 
the variability in rates of psychotic experiences between 
studies,2 the different rates of co-occurrence may reflect 
random deviance around the population mean and it 
may reflect differences in assessment methods between 
the current study, using structured clinical interview, and 
previous studies, which were all based on the Composite 
International Diagnostic Interview.22–25 A further consid-
eration related to the interview method is that symptom 
data were based on dichotomous measures represent-
ing information on lifetime and interval-time (T0-T1) 
presence vs absence. Future studies may benefit from 
continuous scales to assess psychotic symptoms, allow-
ing for the investigation of severity of reported symp-
toms. Furthermore, the current study included relatives 
of patients with nonaffective psychosis. Future studies 
may extend the investigation of symptom connections 
in other groups, particularly patients with affective psy-
chosis or sample by presence of psychotic symptoms 
rather than a specific diagnostic category. Although the 
inclusion of both parents and healthy siblings OAF may 
be considered a strength, it also creates methodological 
issues that require further consideration. Any group dif-
ferences need to be interpreted with caution, since the 
design was unbalanced (N individuals with genetic risk 
vs N in the healthy control group), affecting statistical 
power. Additionally, possible cohort effects need to be 
taken into consideration, in that parents have lived lon-
ger through the period of risk, increasing the probability 
of onset of symptoms in isolation as well as in combi-
nation with each other. One other factor, as mentioned 
above, may be that healthy siblings OAF and parents may 
adapt different answering styles to overt questions about 
psychosis, siblings possibly answering more “defensibly” 
than parents. This could cause an underestimation of 
symptoms in healthy siblings OAF.47,48 Furthermore, the 
current study investigated the association between canna-
bis use, as an environmental risk, and co-occurring hallu-
cinations and delusions with the aid of a measure limited 
to current cannabis use. This does not exclude an effect of 
cannabis exposure at an earlier age.52–54 Additionally, as 
each environmental risk factor was modeled separately, 
any comparisons between them can only be descriptive 
and not direct as the risk factors’ covariance was not 
accounted for.
Studies of  relational models of  psychopathology in 
psychosis can be usefully combined with neuroimaging 
paradigms in order to test to what degree the mechanism 
of progressive connection between perceptual altera-
tions with delusional ideation is associated with under-
lying changes in biology, eg, presynaptic dopaminergic 
changes. Longitudinal high-risk samples using neuroim-
aging measures may be of  particular interest, as these 
permit assessment of  incident psychopathology and the 
temporal order of  interaction between environmental 
risks and neural substrates underlying psychopathology. 
This type of  study would allow investigating neural sub-
strates of  the temporal onset of  symptoms (ie, halluci-
nations and delusions). In addition, this type of  study 
can be used to investigate the possible causal or medi-
ating role of  environmental exposures (eg, childhood 
trauma, cannabis use) in symptom onset and provide 
information about the neural and biological mechanisms 
through which these factors impact on psychosis risk. 
Furthermore, studies comparing coping styles and attri-
bution processes related to hallucinations in individuals 
with only hallucinations to those with both hallucina-
tions and delusions may offer new insights on protective 
mechanisms. These studies may also offer insight in the 
role of  cognitive biases and psychological processes in the 
transition from unusual perceptual experience and aber-
rant salience to delusions, as well as in resilience for delu-
sions in spite of  dopamine dysregulation. Additionally, 
future studies may benefit from distinguishing qualita-
tively different durations of  onset of  psychotic symp-
toms (ie, insidious or acute) and the relationship between 
hallucinations and delusions.55
Supplementary Material
Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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